DNA and Equity
Many individuals who contribute their DNA to genomic studies see little return on their investment, especially when breakthrough drugs are priced out of reach. Even when these drugs are developed from community data, the communities often lack access to them, highlighting systemic inequities in healthcare. A proposed solution involves implementing benefit-sharing models that ensure a portion of revenue from drug sales supports the communities that contributed to the research, fostering economic and cultural revitalization.In this clip
From this podcast
Short Wave
A Call For Equity In Genomics Research
Related Questions